Smoking is associatedwith reduced risk of autoimmune diabetes in adults contrastingwith increased risk in overweight menwith type 2 diabetes

Diabetes Care

Volumn 36, Issue 3, 2013, Pages 604-610

  Rasouli, Bahareh ^a   Grill, Valdemar ^b,c   Midthjell, Kristian ^b   Ahlbom, Anders ^b   Andersson, Tomas ^a,b   Carlsson, Sofia ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; GLUTAMATE DECARBOXYLASE;

ADULT; ANTHROPOMETRY; ARTICLE; AUTOIMMUNE DISEASE; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EDUCATION; FAMILY HISTORY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ONSET AGE; POPULATION RESEARCH; QUESTIONNAIRE; RISK FACTOR; SMOKING HABIT; MIDDLE AGED; SMOKING;

ADULT; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; OVERWEIGHT; SMOKING; YOUNG ADULT;

EID: 84874419308     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-0913     Document Type: Article

References (40)

1. Rehani K, Scott DA, Renaud D, et al. Cotinine-induced convergence of the cholinergic and PI3 kinase-dependent anti-inflammatory pathways in innate immune cells. Biochim Biophys Acta 2008; 1783:375-382
2. Wittebole X, Hahm S, Coyle SM, Kumar A, Calvano SE, Lowry SF. Nicotine exposure alters in vivo human responses to endotoxin. Clin Exp Immunol 2007;147: 28-34
3. Mabley JG, Pacher P, Southan GJ, Salzman AL, Szabó C. Nicotine reduces the incidence of type I diabetes in mice. J Pharmacol Exp Ther 2002;300:876-881
4. Carlsson S, Midthjell K, Grill V; Nord-Trøndelag study. Smoking is associated with an increased risk of type 2 diabetes but a decreased risk of autoimmune diabetes in adults: an 11-year follow-up of incidence of diabetes in the Nord-Trøndelag study. Diabetologia 2004;47: 1953-1956
5. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA2007;298:2654-2664
6. Frati AC, Iniestra F, Ariza CR. Acute effect of cigarette smoking on glucose tolerance and other cardiovascular risk factors. Diabetes Care 1996;19:112-118
7. Liu S, Tinker L, Song Y, et al. A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women. Arch Intern Med 2007;167:1676-1685
8. Berlin I. Smoking-induced metabolic disorders: a review. DiabetesMetab 2008;34: 307-314
9. Ostgren CJ, Lindblad U, Ranstam J, Melander A, Råstam L; Skaraborg Hypertension and Diabetes Project. Associations between smoking and beta-cell function in a non-hypertensive and non-diabetic population. Skaraborg Hypertension and Diabetes Project. Diabet Med 2000;17: 445-450
10. Nagaya T, Yoshida H, Takahashi H, Kawai M. Heavy smoking raises risk for type 2 diabetes mellitus in obese men; but, light smoking reduces the risk in lean men: a follow-up study in Japan. Ann Epidemiol 2008;18:113-118
11. Patja K, Jousilahti P, Hu G, Valle T, Qiao Q, Tuomilehto J. Effects of smoking, obesity and physical activity on the risk of type 2 diabetes in middle-aged Finnish men and women. J Intern Med 2005;258: 356-362
12. Midthjell K, Bjørndal A, Holmen J, Kruger O, Bjartveit K. Prevalence of known and previously unknown diabetes mellitus and impaired glucose tolerance in an adult Norwegian population. Indications of an increasing diabetes prevalence. The Nord-Trøndelag Diabetes Study. Scand J Prim Health Care 1995;13:229-235
13. Holmen J. The Nord-Trøndelag Health Study 1995-97 (HUNT2): objectives, contents, methods and participation. Norsk Epidemiologi 2003;13:19-32
14. Petersen JS, Hejnaes KR, Moody A, et al. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 1994;43:459-467
15. SchlosserM,Mueller PW, Törn C, Bonifacio E, Bingley PJ; Participating Laboratories. Diabetes Antibody Standardization Program: evaluation of assays for insulin autoantibodies. Diabetologia 2010;53: 2611-2620
16. Davies H, Brophy S, Bain SC, et al. GADA testing: the current state of knowledge. Prim Care Diabetes 2009;3:189-191
17. Biesma DH, van Iperen CE, Kraaijenhagen RJ, Marx JJ, van de Wiel HB, van de Wiel A. Red blood cell transfusions for total hip replacement in a regional hospital. A sixyear analysis. Vox Sang 1994;66:270-275
18. Stensvold D, Nauman J, Nilsen TI,Wisløff U, Slørdahl SA, Vatten L. Even low level of physical activity is associated with reduced mortality among people with metabolic syndrome, a population based study (the HUNT 2 study, Norway). BMC Med 2011;9:109
19. Andersson T, Alfredsson L, Källberg H, Zdravkovic S, Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol 2005;20:575-579
20. Toschke AM, Ehlin A, Koletzko B, Montgomery SM. Paternal smoking is associated with a decreased prevalence of type 1 diabetes mellitus among offspring in two national British birth cohort studies (NCDS and BCS70). J Perinat Med 2007; 35:43-47
21. Dahlquist G, Bennich SS, Källén B. Intrauterine growth pattern and risk of childhood onset insulin dependent (type I) diabetes: population based case-control study. BMJ 1996;313:1174-1177
22. Dahlquist G, Källén B. Maternal-child blood group incompatibility and other perinatal events increase the risk for earlyonset type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1992;35:671-675
23. Decochez K, Keymeulen B, Somers G, et al.; Belgian Diabetes Registry. Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Diabetes Care 2000;23:1072-1078
24. Decochez K, Tits J, Coolens JL, et al. High frequency of persisting or increasing isletspecific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry. Diabetes Care 2000;23:838-844
25. Sørgjerd EP, Skorpen F, Kvaløy K,Midthjell K,Grill V. Time dynamics of autoantibodies are coupled to phenotypes and add to the heterogeneity of autoimmune diabetes in adults: the HUNT study, Norway. Diabetologia 2012;55:1310-1318
26. Borg H, Gottsäter A, Fernlund P, Sundkvist G. A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes. Diabetes 2002;51:1754-1762
27. Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol 2002;2:372-377
28. Guslandi M. Long-term effects of a single course of nicotine treatment in acute ulcerative colitis: remission maintenance in a 12-month follow-up study. Int J Colorectal Dis 1999;14:261-262
29. Zhang L, Curhan GC, Hu FB, Rimm EB, Forman JP. Association between passive and active smoking and incident type 2 diabetes in women. Diabetes Care 2011; 34:892-897
30. Yeh HC, Duncan BB, Schmidt MI, Wang NY, Brancati FL. Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study. Ann InternMed 2010; 152:10-17
31. Kowall B, Rathmann W, Strassburger K, et al. Association of passive and active smoking with incident type 2 diabetes mellitus in the elderly population: the KORA S4/F4 cohort study. Eur J Epidemiol 2010;25:393-402
32. Cho NH, Chan JC, Jang HC, Lim S, Kim HL, Choi SH. Cigarette smoking is an independent risk factor for type 2 diabetes: a four-year community-based prospective study. Clin Endocrinol (Oxf) 2009;71: 679-685
33. Midthjell K. Diabetes in adults in Nord-Trøndelag. Epidemiological and public health aspects of diabetes mellitus in a large, nonselected Norwegian population. Trøndheim, The Norwegian University of Science and Technology (NTNU), 2001
34. Beziaud F, Halimi JM, Lecomte P, Vol S, Tichet J. Cigarette smoking and diabetes mellitus. Diabetes Metab 2004;30:161-166
35. Mariner DC, Ashley M, Shepperd CJ, Mullard G, Dixon M. Mouth level smoke exposure using analysis of filters from smoked cigarettes: a study of eight countries. Regul Toxicol Pharmacol 2011;61 (Suppl.):S39-S50
36. Onat A, Ozhan H, Esen AM, et al. Prospective epidemiologic evidence of a "protective" effect of smoking on metabolic syndrome and diabetes among Turkish womendwithout associated overall health benefit. Atherosclerosis 2007;193: 380-388
37. Onat A, Erginel-Unaltuna N, Coban N, Ciçek G, Yuksel H. APOC3-482C.T polymorphism, circulating apolipoprotein C-III and smoking: interrelation and roles in predicting type-2 diabetes and coronary disease. Clin Biochem 2011;44: 391-396
38. Olivieri O, Bassi A, Stranieri C, et al. Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease. J Lipid Res 2003;44:2374-2381
39. Midthjell K, Holmen J, Bjørndal A, Lund-Larsen G. Is questionnaire information valid in the study of a chronic disease such as diabetes? The Nord-Trøndelag diabetes study. J Epidemiol Community Health 1992;46:537-542
40. Gorber SC, Schofield-Hurwitz S, Hardt J, Levasseur G, Tremblay M. The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. Nicotine Tob Res 2009;11:12-24